Top Midday Stories: Goldman Shares Fall Despite Q1 Earnings Topping Estimates; Revolution's Pancreatic Cancer Drug Met Key Study Goals
Affected assets and topics
Why it matters
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.
Article tone
Neutral
How the article is written, as reported by the source.
Expected market reaction
Evidence trail
Evidence
Source
Yahoo Finance
Claim
Top Midday Stories: Goldman Shares Fall Despite Q1 Earnings Topping Estimates; Revolution's Pancreatic Cancer Drug Met Key Study Goals
Affected assets
DOW, NASDAQ
AI inference
Neutral · 94%
Generated
2026-04-13 15:40
AI provenance
Technical identifiers
- Provider tag
- huggingface-ProsusAI/finbert
- Analysis version
- huggingface-ProsusAI/finbert
- Article id
- 70243
- Timeframe
- 6h
Prediction lifecycle
-
FinBERT NASDAQ Neutral 94%Generated 6h Excluded
Expired: not evaluated within 7 days of its 6h timeframe elapsing
-
FinBERT DOW Neutral 94%Generated 6h Excluded
Expired: not evaluated within 7 days of its 6h timeframe elapsing
Logged at publication, scored automatically once the window closes — never edited.
Original source
The Dow Jones Industrial Average was down while the S&P 500 and Nasdaq Composite were up in late-mor
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on April 13, 2026. Analysis and insights provided by AnalystMarkets AI.